Age-Dependent Efficacy of Ezetimibe for Low-Density Lipoprotein Cholesterol Reduction in Japanese Patients with or without Type 2 Diabetes Mellitus

Ezetimibe reduces cardiovascular risk by lowering the levels of low-density lipoprotein cholesterol (LDL-C). However, there is limited information regarding the factors associated with ezetimibe-mediated LDL-C reduction. We investigated the factors associated with LDL-C reduction after ezetimibe adm...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamaguchi, Satoshi, Oba, Kageyuki, Higa, Moritake, Arasaki, Osamu, Shimabukuro, Michio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7356893/
https://www.ncbi.nlm.nih.gov/pubmed/32492927
http://dx.doi.org/10.3390/jcm9061675

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7356893/
https://www.ncbi.nlm.nih.gov/pubmed/32492927
http://dx.doi.org/10.3390/jcm9061675

Ejemplares similares